Interleukin-33, a Target of Parathyroid Hormone and Oncostatin M, Increases Osteoblastic Matrix Mineral Deposition and Inhibits Osteoclast Formation in VitroHasnawati Saleh, J Quinn, Matthew T. Gillespie et al.|Endocrinology|2011Cited by 72
Osteoclast formation elicited by interleukin-33 stimulation is dependent upon the type of osteoclast progenitorDamien G. Eeles, J Quinn, Jason M. Hodge et al.|Molecular and Cellular Endocrinology|2014Cited by 23
Abstract 2933: HSP90 inhibiting anti-cancer therapeutics enhance bone loss by increasing osteoclast formation: Mechanism of action.A. Gabrielle J. van der Kraan, John T. Price, Julian M.W. Quinn et al.|Cancer Research|2013Cited by 0